Evidence map›Paper›PMID 29911128›Full record

ArticleInternational journal of clinical anesthesiology

Clinical Implications of Bilirubin-Associated Neuroprotection and Neurotoxicity.

Nicholas V Mendez, Jeffrey A Wharton, Jenna L Leclerc, Spiros L Blackburn, Martha V Douglas-Escobar, Michael D Weiss, Christoph N Seubert, Sylvain Doré

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical anesthesiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Plasma metabonomic study on the effect ofMolecular medicine reports · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nicholas V MendezDepartment of Anesthesiology, College of Medicine, University of Florida, USA.
Jeffrey A WhartonDepartment of Anesthesiology, College of Medicine, University of Florida, USA.
Jenna L LeclercDepartment of Anesthesiology, College of Medicine, University of Florida, USA.
Spiros L BlackburnDepartment of Neurosurgery, College of Medicine, University of Florida, USA.
Martha V Douglas-EscobarDivision of Neonatology, Department of Pediatrics, College of Medicine, University of Florida, USA.
Michael D WeissDivision of Neonatology, Department of Pediatrics, College of Medicine, University of Florida, USA.
Christoph N SeubertDepartment of Anesthesiology, College of Medicine, University of Florida, USA.
Sylvain DoréDepartment of Anesthesiology, College of Medicine, University of Florida, USA.
University of Florida · US

Funding

Role of Prostaglandin Receptors in StrokeR01NS046400 · NINDS · UNIVERSITY OF FLORIDA · PI DORE, SYLVAIN · 2003 to 2014
$3.0M
Better Understanding of the Neuroprotective Mechanisms of Korean Ginseng in StrokR01AT007429 · NCCIH · UNIVERSITY OF FLORIDA · PI DORE, SYLVAIN · 2012 to 2016
$2.2M
NCCIH NIH HHS R01 AT007429NINDS NIH HHS R01 NS046400
6 · The paper itself

Abstract

Bilirubin is a primary product of heme catabolism and exhibits both neuroprotective and neurotoxic effects. When present at physiologic concentrations, bilirubin is a potent antioxidant and serves to protect brain tissue from oxidative stress insults. The use of the anesthetic propofol attenuates ischemic injury in rats by exploiting these neuroprotective properties. At pathologic levels, bilirubin has been implicated as a neurotoxic agent, demonstrating the ability to aggregate and adhere to cellular membranes, thereby disrupting normal cellular function. Bilirubin-associated toxicities are amplified by administering drugs such as anesthetics that compete with bilirubin for albumin binding sites, resulting in increased plasma bilirubin concentrations. As such, it is crucial that bilirubin is considered in the critical care management of patients with hemorrhagic stroke, cerebral ischemic damage, and critically ill newborns.

Indexed as

Heme oxygenaseHyperbilirubinemiaIschemiaOxidative stressStroke

Identifiers

PMID29911128
PMCPMC5998657
OpenAlexW2990759885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.